3-year Disease-free Survival (DBCOND0168363)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT06561620	Befotertinib Adjuvant Therapy in Stage IA2-IB NSCLC Patients	Befotertinib	treatment	4	recruiting